43 Amendments of Frédérique RIES related to 2011/0401(COD)
Amendment 44 #
Proposal for a regulation
Recital 22 a (new)
Recital 22 a (new)
(22a) Horizon 2020 should also help persuade European researchers to remain in Europe, attract researchers from the whole world to Europe and make Europe a more attractive destination for the best researchers. Consideration should therefore be given at European level to establishing attractive, coordinated tax arrangements for researchers.
Amendment 48 #
Proposal for a regulation
Recital 24
Recital 24
(24) Research and innovation activities supported by Horizon 2020 should respect fundamental ethical principles. The reasoned, regularly updated opinions of the European Group on Ethics in Science and New Technologies should be taken into account, which entails, as a prerequisite, a transparent method of selection underpinned by the independence and scientific expertise of the members of the European Group on Ethics in Science and New Technologies (EGE). Research activities should also take into account Article 13 TFEU and reduce the use of animals in research and testing, with a view ultimately to replacing animal use. All activities should be carried out ensuring a high level of human health protection in accordance with Article 168 TFEU.
Amendment 52 #
Proposal for a regulation
Recital 25
Recital 25
(25) The European Commission does not explicitly solicit the use of human embryonic stem cellsis concerned about matters of fairness in the use of human stem cells, whether adult, embryonic or from the umbilical cord. The use of human stem cells, be they adult or embryonic, if any, depends on the judgement of the scientists in view of the therapeutic objectives they want to achieve and is subject to stringent Ethics Review. No pProjects involving the use of human embryonic stem cells shouldmay be funded that does not obtain the necessary approvals from the Member States. No activity should be funded that is forbidden in all Member States. No activity should be funded in a Member State where such activity is forbiddenprovided that they have been duly approved by the Member States.
Amendment 58 #
Proposal for a regulation
Recital 25 a (new)
Recital 25 a (new)
(25a) The Commission must take better account in the framework programme of research on cells extracted from umbilical cord blood (capacity for differentiation, proliferation and for autologous or allogeneic use, absence of immunological reaction in the patient receiving the cells), which have already been successfully used to treat certain conditions.
Amendment 60 #
Proposal for a regulation
Recital 25 b (new)
Recital 25 b (new)
Amendment 62 #
Proposal for a regulation
Recital 27
Recital 27
(27) SMEs constitute a significantn essential source of innovation and, growth and jobs in Europe. Therefore a strong participation of SMEs, as defined in Commission Recommendation 2003/361/EC of 6 May 2003, is needed in Horizon 2020. This should support the aims of the Small Business Act.
Amendment 86 #
Proposal for a regulation
Article 6 – paragraph 2 – subparagraph 1 – point b
Article 6 – paragraph 2 – subparagraph 1 – point b
(b) Industrial and post-industrial leadership, EUR 205280 million;
Amendment 89 #
Proposal for a regulation
Article 6 – paragraph 2 – subparagraph 1 – point c
Article 6 – paragraph 2 – subparagraph 1 – point c
(c) Societal challenges, EUR 350888 million.
Amendment 97 #
Proposal for a regulation
Article 7 – paragraph 1 – point b – point iii
Article 7 – paragraph 1 – point b – point iii
(iii) have close political, economic and geographical links to the Union;
Amendment 132 #
Proposal for a regulation
Article 16 – paragraph 4
Article 16 – paragraph 4
4. Research on human stem cells, bothwhether adult and, embryonic or from the umbilical cord, may be financed, depending both on the contents of the scientific proposal and the legal framework of the Member States involved. Research on embryonic stem cells may only be carried out using supernumerary embryos conceived via in vitro fertilisation, and which are not needed for the purposes of reproduction. No funding shall be granted for research activities that are prohibited in all the Member States. No activity shall be funded in a Member State where such activity is forbidden. However, medical research on all types of stem cell shall be funded in Member States where such activity is authorised.
Amendment 182 #
Proposal for a regulation
Annex I – part II – point 1.2.1. – introductory paragraph
Annex I – part II – point 1.2.1. – introductory paragraph
The specific objective of nanotechnologies research and innovation is to secuprepare Union leadership in this high growth global market, by stimulating investment and patents in nanotechnologies and their uptake in high added-value, competitive products and services across a range of applications and sectors.
Amendment 184 #
Proposal for a regulation
Annex I – part II – point 1.2.1. – paragraph 1
Annex I – part II – point 1.2.1. – paragraph 1
By 2015, the Commission will review all relevant legislation to ensure safety for all applications of nanomaterials in products with potential health, environmental or safety impacts over their life cycle. By 2020, nanotechnologies will be mainstreamed, that is seamlessly integrated with most technologies and applications, driven by consumer benefits, quality of life, sustainable development and the strong industrial potential for achieving previously unavailable solutions for productivity and resource efficiency.
Amendment 190 #
Proposal for a regulation
Annex I – part II – point 1.2.3. – point a – paragraph 1
Annex I – part II – point 1.2.3. – point a – paragraph 1
Aiming at fundamentally new products enabling sustainable solutions in a wide range of sectors, in particular electronics, medicine, new energy sources and materials.
Amendment 191 #
Proposal for a regulation
Annex I – part II – point 1.2.3. – point b
Annex I – part II – point 1.2.3. – point b
(b) Ensuring the safe development and application of nanotechnologies, particularly when they are used to make products which will come into direct contact with the human body.
Amendment 221 #
Proposal for a regulation
Annex I – part II – point 3.1 – paragraph 2
Annex I – part II – point 3.1 – paragraph 2
However, SMEs have – despite their important economic and employment share and significant innovation potential – size- related problems to become more innovative and more competitive. Although Europe produces a similar number of start- up companies than the United States of America, European SMEs are finding it much harder to grow into large companies than their US counterparts. The internationalised business environment with increasingly interlinked value chains puts further pressure on them. SMEs need to enhance their innovation capacity and to have ready access to different forms of financial support (loans, guarantees, venture capital). They need to generate, take up and commercialise new knowledge and business ideas faster and to a greater extent to compete successfully on fast evolving global markets. The challenge is to stimulate more innovation in SMEs, thereby enhancing their competitiveness and growth.
Amendment 235 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 2
Annex I – part III – point 1.1 – paragraph 2
The cost of Union health and social care systems is rising with care and prevention measures in all ages increasingly expensive, the number of Europeans aged over 65 expected to nearly double from 85 million in 2008 to 151 million by 2060, and those over 80 to rise from 22 to 61 million in the same period. Reducing or containing these costs such that they do not become unsustainable depends in part on ensuringbetter informing and increasing the responsibility of citizens regarding health determinants in order to ensure the lifelong health and wellbeing of all and therefore on the effective prevention, treatment and management of disease and disability.
Amendment 287 #
Proposal for a regulation
Recital 21 a (new)
Recital 21 a (new)
(21a) Industry and SMEs are essential in bringing research results into the markets. Horizon 2020 should leverage investment from the private sector in RDI in order to bring combined public and private R&D investment to 3% of GDP, of which the private sector should be expected to contribute with two thirds.
Amendment 293 #
Proposal for a regulation
Recital 22 a (new)
Recital 22 a (new)
(22a) Horizon 2020 should also help persuade European researchers to remain in Europe, attract researchers from the whole world to Europe and make Europe a more attractive destination for the best researchers. Consideration should therefore be given at EU level to establishing attractive, coordinated tax arrangements for researchers.
Amendment 305 #
Proposal for a regulation
Annex I – part III – point 2.1 – introductory paragraph
Annex I – part III – point 2.1 – introductory paragraph
The specific objective is to secure sufficient supplies of safe and high quality food and other bio-based products, by developing productive and resource- efficient primary production systems, fostering related ecosystem servicbringing together quantitative et qualitative approaches, along side competitive and low carbon supply chains. This will accelerate the transition to a sustainable European bio-economy.
Amendment 307 #
Proposal for a regulation
Annex I – part III – point 2.1 – paragraph 1
Annex I – part III – point 2.1 – paragraph 1
Over the coming decades, Europe will be challenged by increased competition for limited and finite natural resources, by the effects of climate change, in particular on primary production systems (agriculture, forestry, fisheries and aquaculture) and by the need to provide a sustainable, safe and secure food supply for the European and an increasing global population. A 70 % increase of the world food supply is estimated to be required to feed the 9 billion global population by 2050. This food emergency does not justify the current imbalance between often surplus national production levels and the steady rise in food imports, nor does it provide a reason for the increasing complexity of the global food network. Hence the importance of the European Union having better control of the supply circuits, taking into account, as a matter of priority, seasonal cycles, the origin of products and the ability to track food. Agriculture accounts for about 10 % of Union greenhouse gases emissions, and while declining in Europe, global emissions from agriculture are projected to increase up to 20 % by 2030. Furthermore, Europe will need to ensure sufficient supplies of raw materials, energy and industrial products, under conditions of decreasing fossil carbon resources (oil and liquid gas production expected to decrease by about 60 % by 2050), while maintaining its competitiveness. Bio-waste (estimated at up to 138 million tonnes per year in the Union, of which up to 40 % is land-filled) represents a huge problem and cost, despite its high potential added value. For example, an estimated 30 % of all food produced in developed countries is discarded. Major changes are needed to reduce this amount by 50 % in the Union by 2030. In addition, national borders are irrelevant in the spread of animal and plant pests and diseases, including zoonotic diseases, and food borne pathogens. While effective national prevention measures are needed, action at Union level is essential for ultimate control and the effective running of the single market. The challenge is complex, affects a broad range of interconnected sectors and requires a plurality of approaches.
Amendment 308 #
Proposal for a regulation
Recital 24
Recital 24
(24) Research and innovation activities supported by Horizon 2020 should respect fundamental ethical principles. The reasoned, regularly updated opinions of the European Group on Ethics in Science and New Technologies (EGE) should be taken into account, which entails, as a prerequisite, a transparent method of selection underpinned by the independence and scientific expertise of the EGE members. Research activities should also take into account Article 13 TFEUof the Treaty on the Functioning of the European Union and reduce the use of animals in research and testing, with a view ultimately to replacing animal use. All activities should be carried out ensuring a high level of human health protection in accordance with Article 168 TFEU. of the Treaty on the Functioning of the European Union.
Amendment 322 #
Proposal for a regulation
Recital 25
Recital 25
(25) The European Commission does not explicitly solicit the use of human embryonic stem cellsis concerned about matters of fairness in the use of human stem cells, whether adult, embryonic or from the umbilical cord. The use of human stem cells, be they adult or embryonic, if any, depends on the judgement of the scientists in view of the therapeutic objectives they want to achieve and is subject to stringent Ethics Review. No pProjects involving the use of human embryonic stem cells shouldmay be funded that does not obtain the necessary approvals fromprovided that they have been duly approved by the Member States concerned. No activity should be funded that is forbidden in all Member States. No activity should be funded in a Member State where such activity is forbidden. However, medical research on all types of stem cell shall be funded in Member States where such activity is authorised.
Amendment 326 #
Proposal for a regulation
Annex I – part III – point 2.3 – point c a (new)
Annex I – part III – point 2.3 – point c a (new)
(c a) Another objective is to fight against the homogenisation of species present in inland seas and rivers, which has a significant impact on the functioning of ecosystems, particularly as a result of increased resistance to disturbances.
Amendment 331 #
Proposal for a regulation
Recital 25 a (new)
Recital 25 a (new)
(25a) The Commission should take better account in the framework programme of research on cells extracted from umbilical cord blood (capacity for differentiation, for proliferation and for autologous or allogeneic use, absence of immunological reaction in the patient receiving the cells), which have already been successfully used to treat certain conditions.
Amendment 333 #
Proposal for a regulation
Recital 25 b (new)
Recital 25 b (new)
(25b) The recent discovery of induced pluripotent stem cells (iPSCs) has opened up a new avenue for research, over and beyond the opportunities for research on adult and embryonic stem cells that have existed for several years, and has thus offered new hope to patients awaiting treatment. The Union should therefore take action, bearing in mind the following: - the scientific community’s interest in all types of research; - the need to strike a balance between the various ways of researching stem cells, without favouring any one over the others; - the importance of unprejudiced consideration of the ethical problems raised by each category of stem cells.
Amendment 350 #
Proposal for a regulation
Recital 27
Recital 27
(27) SMEs constitute a significantn essential source of innovation and, growth and jobs in Europe. Therefore a strong participation of SMEs, as defined in Commission Recommendation 2003/361/EC of 6 May 2003, is needed in Horizon 2020. This should support the aims of the Small Business Act.
Amendment 448 #
Proposal for a regulation
Article 7 – paragraph 1 – point b – point iii
Article 7 – paragraph 1 – point b – point iii
(iii) have close political, economic and geographical links to the Union;
Amendment 485 #
Proposal for a regulation
Article 13 – paragraph 1
Article 13 – paragraph 1
1. Linkages and interfaces shall be implemented across and within the priorities of Horizon 2020. Particular attention shall be paid in this respect to the development and application of key enabling and industrial technologies, to bridging from discovery to market application, to cross-disciplinary research and innovation, to social and economic sciences and humanities, to climate change and sustainable development, to fostering the functioning and achievement of the ERA, to cooperation with third countries, to responsible research and innovation including a gender perspective, to SME involvement in research and innovation and the broader private sector participation, and to enhancing the attractiveness of the research profession and to facilitating cross-border and cross- sector mobility of researchers.
Amendment 576 #
Proposal for a regulation
Article 16 – paragraph 4
Article 16 – paragraph 4
4. Research on human stem cells, bothwhether adult and, embryonic or from the umbilical cord, may be financed, depending both on the contents of the scientific proposal and the legal framework of the Member States involved. Research on embryonic stem cells may only be carried out using supernumerary embryos conceived via in vitro fertilisation and not needed for the purposes of reproduction. No funding shall be granted for research activities that are prohibited in all the Member States. No activity shall be funded in a Member State where such activity is forbidden. However, medical research on all types of stem cell shall be funded in Member States where such activity is authorised.
Amendment 593 #
Proposal for a regulation
Article 17 – paragraph 1
Article 17 – paragraph 1
Horizon 2020 shall be implemented in a way which is complementary to other Union funding programmes, including the Structural Funds, the Programme for the Competitiveness of Enterprises and SMEs (COSME), and Erasmus for all.
Amendment 608 #
Proposal for a regulation
Article 18 – paragraph 2
Article 18 – paragraph 2
2. Specific actions shall be undertaken within the specific objective ‘Leadership in enabling and industrial technologies’ set out in Point 1 of Part II of Annex I and each of the specific objectives under the priority ‘Societal challenges’ set out in Points 1 to 6 of Part III of Annex I. These specific actions shall take the form of a dedicated SME instrument that is targeted at all types of SMEs with an innovation potential and shall be implemented in a consistent manner and tailored to the needs of SMEs as set out under the specific objective ‘Innovation in SMEs’ in Point 3.3.(a) of Part II of Annex I. It is essential that SMEs are integrated within the full value chain in order to get access to all opportunities in Horizon 2020.
Amendment 630 #
Proposal for a regulation
Article 18 – paragraph 3
Article 18 – paragraph 3
3. The integrated approach set out in paragraphs 1 and 2 is expected toand the simplification of the application procedures should lead to around 15% of the total combined budget for the specific objective on ‘Leadership in enabling and industrial technologies’ and the priority ‘Societal challenges’ going to SMEs.
Amendment 633 #
Proposal for a regulation
Article 18 – paragraph 3 a (new)
Article 18 – paragraph 3 a (new)
3 a. Furthermore, at least 10% of the budget of pillar 2 and 3 should be earmarked for the dedicated SME instrument.
Amendment 1050 #
Proposal for a regulation
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.1 – paragraph 1
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.1 – paragraph 1
The specific objective of nanotechnologies research and innovation is to secuprepare Union leadership in this high growth global market, by stimulating investment and patents in nanotechnologies and their uptake in high added-value, competitive products and services across a range of applications and sectors.
Amendment 1051 #
Proposal for a regulation
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.1 – paragraph 2
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.1 – paragraph 2
By 2015, the Commission will review all relevant legislation to ensure safety for all applications of nanomaterials in products with potential health, environmental or safety impacts over their life cycle. By 2020, nanotechnologies will be mainstreamed, that is seamlessly integrated with most technologies and applications, driven by consumer benefits, quality of life, sustainable development and the strong industrial potential for achieving previously unavailable solutions for productivity and resource efficiency.
Amendment 1060 #
Proposal for a regulation
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.3 – point a – paragraph 1
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.3 – point a – paragraph 1
Aiming at fundamentally new products enabling sustainable solutions in a wide range of sectors, particularly electronics, medicine and new energies and materials.
Amendment 1063 #
Proposal for a regulation
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.3 – point b – introductory part
Annex 1 – Part 2 – point 1 – point 1.2 – point 1.2.3 – point b – introductory part
(b) Ensuring the safe development and application of nanotechnologies, particularly when they are used in the manufacture of products that will come into direct contact with the human body
Amendment 1249 #
Proposal for a regulation
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2
All of the specific objectives on societal challenges and on leadership in enabling and industrial technologies will apply the dedicated SME instrument and will allocate an amount for this10% of their allocated budget for the SME instrument.
Amendment 1251 #
Proposal for a regulation
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2 a (new)
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2 a (new)
The dedicated SME instrument should be centrally managed in order to ensure coherent application of rules, visibility of the Instrument, and a single entry point, facilitating participation of SMEs. The SME instrument should contribute to the specific objectives of the Leadership in Enabling and Industrial Technologies and Societal Challenges.
Amendment 1254 #
Proposal for a regulation
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2 b (new)
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2 b (new)
This instrument shall create the necessary flexibility to allow for the integration of SMEs at project runtime and for limited shorter-than-project timeframes into research projects. It shall also allow the creation of a new category of smaller (micro) projects for SMEs that can be created independently or as spin-offs from larger research projects.
Amendment 1255 #
Proposal for a regulation
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2 c (new)
Annex 1 – Part 2 – point 3 – point 3.3 – point a – paragraph 2 c (new)
The SME instrument shall be subjected to an in-depth mid-term review. If the absorption objectives of the SME instrument are not met, the remaining funds shall be reallocated to the pillars of industrial leadership and societal challenges.
Amendment 1275 #
Proposal for a regulation
Annex 1 – Part 3 – point 1 – point 1.1 – paragraph 3
Annex 1 – Part 3 – point 1 – point 1.1 – paragraph 3
The cost of Union health and social care systems is rising with care and prevention measures in all ages increasingly expensive, the number of Europeans aged over 65 expected to nearly double from 85 million in 2008 to 151 million by 2060, and those over 80 to rise from 22 to 61 million in the same period. Reducing or containing these costs such that they do not become unsustainable depends in part on ensuringinforming people better and encouraging responsible health choices so as to optimise the lifelong health and wellbeing of all and therefore on the effective prevention, treatment and management of disease and disability.
Amendment 1368 #
Proposal for a regulation
Annex 1 – Part 3 – point 2 – point 2.1 – paragraph 2
Annex 1 – Part 3 – point 2 – point 2.1 – paragraph 2
Over the coming decades, Europe will be challenged by increased competition for limited and finite natural resources, by the effects of climate change, in particular on primary production systems (agriculture, forestry, fisheries and aquaculture) and by the need to provide a sustainable, safe and secure food supply for the European and an increasing global population. A 70 % increase of the world food supply is estimated to be required to feed the 9 billion global population by 2050. This food emergency does not justify the current imbalance between often surplus national production levels and the steady rise in food imports, nor does it provide a reason for the increasing complexity of the global food network. Hence the importance of the European Union having better control of the supply circuits, taking into account, as a matter of priority, seasonal cycles, the origin of products and the ability to track food. Agriculture accounts for about 10 % of Union greenhouse gases emissions, and while declining in Europe, global emissions from agriculture are projected to increase up to 20 % by 2030. Furthermore, Europe will need to ensure sufficient supplies of raw materials, energy and industrial products, under conditions of decreasing fossil carbon resources (oil and liquid gas production expected to decrease by about 60 % by 2050), while maintaining its competitiveness. Bio-waste (estimated at up to 138 million tonnes per year in the Union, of which up to 40 % is land-filled) represents a huge problem and cost, despite its high potential added value. For example, an estimated 30 % of all food produced in developed countries is discarded. Major changes are needed to reduce this amount by 50 % in the Union by 203026 . In addition, national borders are irrelevant in the spread of animal and plant pests and diseases, including zoonotic diseases, and food borne pathogens. While effective national prevention measures are needed, action at Union level is essential for ultimate control and the effective running of the single market. The challenge is complex, affects a broad range of interconnected sectors and requires a plurality of approaches.